Epigenetic targets in the diagnosis and treatment of prostate cancer

Murugesan Manoharan, Kavitha Ramachandran, Mark S. Soloway, Rakesh Singal

Research output: Contribution to journalReview articlepeer-review

20 Scopus citations


Prostate cancer (PC) is one of leading cause of cancer related deaths in men. Various aspects of cancer epigenetics are rapidly evolving and the role of 2 major epigenetic changes including DNA methylation and histone modifications in prostate cancer is being studied widely. The epigenetic changes are early event in the cancer development and are reversible. Novel epigenetic markers are being studied, which have the potential as sensitive diagnostic and prognostic marker. Variety of drugs targeting epigenetic changes are being studied, which can be effective individually or in combination with other conventional drugs in PC treatment. In this review, we discuss epigenetic changes associated with PC and their potential diagnostic and therapeutic applications including future areas of research.

Original languageEnglish (US)
Pages (from-to)11-18
Number of pages8
JournalInternational Braz J Urol
Issue number1
StatePublished - 2007


  • DNA methylation
  • Epigenesis
  • Genetic
  • Prostate cancer

ASJC Scopus subject areas

  • Nephrology


Dive into the research topics of 'Epigenetic targets in the diagnosis and treatment of prostate cancer'. Together they form a unique fingerprint.

Cite this